QA: Homology Medicines Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001661998_2023_Homology_Medicines_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001661998, Homology Medicines Inc.

  xvar xval
0 AssetsCurrent 181,015,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,078,000
3 remainder_Assets 46,377,000
4 LiabilitiesCurrent 22,576,000
5 LiabilitiesNoncurrent 27,916,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 38,138,000
9 ResearchAndDevelopmentExpense 98,351,000
10 remainder_Expenses 715,000
11 remainder_Revenues 3,208,000
12 remainder_NetIncome 128,991,000
13 remainder_ComprehensiveNetIncome -397,000
  yvar yval
0 Assets 228,470,000
1 Liabilities 50,492,000
2 Expenses 137,204,000
3 Revenues 3,208,000
4 StockholdersEquity 177,978,000
5 NetIncome -5,005,000
6 ComprehensiveNetIncome -5,203,500
7 BaseVar 274,381,000
8 EconomicCapitalRatio 2.16

Edgar->Model Mapping

Feature Distribution

Change over Time